Recent progress of targeted nanocarriers in diagnostic, therapeutic, and theranostic applications in colorectal cancer
H Choudhury, M Pandey, V Saravanan, ATY Mun… - Biomaterials …, 2023 - Elsevier
Cancer at the lower end of the digestive tract, colorectal cancer (CRC), starts with
asymptomatic polyps, which can be diagnosed as cancer at a later stage. It is the fourth …
asymptomatic polyps, which can be diagnosed as cancer at a later stage. It is the fourth …
[HTML][HTML] Neuropilins as potential biomarkers in hepatocellular carcinoma: a systematic review of basic and clinical implications
P Fernández-Palanca, T Payo-Serafín… - Clinical and …, 2023 - ncbi.nlm.nih.gov
Hepatocellular carcinoma (HCC) is one of the most common and deadly cancers worldwide
and is characterized by complex molecular carcinogenesis. Neuropilins (NRPs) NRP1 and …
and is characterized by complex molecular carcinogenesis. Neuropilins (NRPs) NRP1 and …
Tumor cells-derived exosomal circVCP promoted the progression of colorectal cancer by regulating macrophage M1/M2 polarization
Y Tang, S Hu, T Li, X Qiu - Gene, 2023 - Elsevier
Background Colorectal cancer (CRC) is among the most frequent tumors of the digestive
tract and the second leading cause of cancer death worldwide. Tumor-associated …
tract and the second leading cause of cancer death worldwide. Tumor-associated …
Expression of CKS2 in hepatocellular carcinoma: correlation with survival outcomes and immune microenvironment
R Zhi, P Hao, W Li, H Zhao - Journal of Hepatocellular Carcinoma, 2023 - Taylor & Francis
Purpose Cyclin-dependent kinase regulatory subunit 2 (CKS2) has an important function in
regulating cancer progression and cell cycle. This research aims to ascertain how CKS2 …
regulating cancer progression and cell cycle. This research aims to ascertain how CKS2 …
[HTML][HTML] Phosphotriesterase-related protein as a novel prognostic predictor for hepatocellular carcinoma patients
X Feng, Y Zhou, S Pang, C Yang… - Chinese Clinical …, 2023 - cco.amegroups.org
Background: Hepatocellular carcinoma (HCC) is the sixth incidence of cancer and the third
leading cause of cancer mortality in the world. Facing the ever-increasing population of HCC …
leading cause of cancer mortality in the world. Facing the ever-increasing population of HCC …
Revealing neuropilin expression patterns in pancreatic cancer: From single‑cell to therapeutic opportunities
Pancreatic cancer, one of the most fatal types of human cancers, includes several non‑
epithelial and stromal components, such as activated fibroblasts, vascular cells, neural cells …
epithelial and stromal components, such as activated fibroblasts, vascular cells, neural cells …
Risk versus Benefit of Tyrosine Kinase Inhibitors for Hepatocellular Carcinoma: A Systematic Review and Meta‐Analysis of Randomized Controlled Trials
T Payo‐Serafín, C Méndez‐Blanco… - Clinical …, 2024 - Wiley Online Library
Although the treatment landscape has rapidly evolved over the last years, hepatocellular
carcinoma (HCC) is one of the most lethal cancers. With recent advances, both …
carcinoma (HCC) is one of the most lethal cancers. With recent advances, both …
[HTML][HTML] Diagnostic and Predictive Tissue Markers in GI Cancers
S Chillotti, F Vasuri - Cancers, 2023 - mdpi.com
The compelling advancements in systemic targeted therapies for cancer drastically changed
the role of histopathological analyses in recent decades. Indeed, the identification and …
the role of histopathological analyses in recent decades. Indeed, the identification and …